Psychedelic therapy treatment center in Cozumel, Mexico
MindScape Retreat
Legal Psychedelic Treatment. Cozumel, Mexico

Psychedelic Therapy in
Mexico

Medical-grade legal psychedelic treatment in Cozumel. Ibogaine HCL & TA, 5-MeO-DMT, psilocybin, and NAD+ infusions administered by a board-certified physician. 900+ successful patients from 40+ countries.

Begin Your Screening
900+
Patients Treated
From 40+ countries. 20+ years combined experience.
4
Psychedelic Protocols
Ibogaine HCL, TA, 5-MeO-DMT, psilocybin, NAD+
Dr. Arellano
Medical Director
Board-certified physician. Advanced cardiology screening.
Cozumel
Location
Caribbean island. 45 min from Cancun. Legal jurisdiction.
DA
Medically reviewed by Dr Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 900 patients treated.
Last reviewed: March 2026

Legal Status & Regulatory Framework

Why Psychedelic Therapy Is Legal in Mexico

Mexico's regulatory environment differs significantly from the United States. While psilocybin, MDMA, and most classical psychedelics remain controlled substances, Mexico allows medical professionals to administer select psychoactive compounds under clinical supervision in licensed treatment facilities. Ibogaine — derived from the African iboga plant — is not listed on Mexico's controlled substances schedule and is therefore legal to possess, transport, and administer in a medical context.

5-MeO-DMT and psilocybin therapy exist in a regulated gray area. MindScape Retreat operates within Cozumel's medical framework with full compliance to state health regulations. Patients travel to Mexico legally; they receive treatment; and they return home with no legal consequences under U.S. law, as they have not broken any domestic laws by receiving treatment abroad.

This regulatory difference — combined with Mexico's centuries-old indigenous tradition of sacred plant medicine — makes Cozumel one of the world's few locations where multiple psychedelic modalities can be safely administered in a professional medical setting.

Treatment Modalities

Four Psychedelic Protocols Available

MindScape Retreat offers a synergistic approach. We do not rely on a single molecule. Instead, we combine multiple compounds based on your diagnosis, history, and treatment goals.

Ibogaine HCL and Ibogaine TA (Total Alkaloid) form the foundation of most protocols. The HCL provides a rapid flood-dose experience with strong visionary and introspective effects; the TA retains all 12 natural alkaloids from the iboga root, delivering neuroprotection, anti-inflammatory action, and emotional depth that HCL alone cannot replicate. We are the only center that uses both forms in sequence.

5-MeO-DMT (Bufo alvarius venom) is the most potent naturally occurring psychedelic. A 15–45 minute ceremony that produces complete ego dissolution, profound peace, and lasting reductions in depression and existential suffering. We reserve 5-MeO-DMT for patients already neuroplastically primed through ibogaine, creating a synergistic state unavailable through either medicine alone.

Psilocybin ceremonies (magic mushroom tea) provide a gentler, more visionary experience than 5-MeO-DMT, ideal for patients seeking insight, emotional processing, and spiritual reconnection without total ego loss. NAD+ IV infusions support cellular energy recovery, particularly valuable during ibogaine protocols, repairing mitochondrial damage from years of substance use or illness.

Conditions Treated

Who Benefits from Legal Psychedelic Therapy

Opioid & Substance Addiction

Ibogaine interrupts addiction within a single session. Patients report 70–80% abstinence success rates when combined with aftercare. Most effective for heroin, fentanyl, alcohol, cocaine.

Treatment-Resistant Depression

When SSRIs, SNRIs, and therapy have failed, 5-MeO-DMT and psilocybin produce rapid, lasting symptom relief by dissolving rigid thought patterns and restoring emotional openness.

PTSD & Complex Trauma (C-PTSD)

Psychedelics facilitate safe trauma processing. Ibogaine provides introspection; psilocybin aids emotional release; 5-MeO-DMT dissolves the core fear state. Patients report 60–75% symptom reduction.

Anxiety & Existential Distress

Generalized anxiety, health anxiety, and existential suffering respond powerfully to 5-MeO-DMT's dissolution of self-referential worry and psilocybin's perspective shift. Relief persists for months post-treatment.

Traumatic Brain Injury (TBI) & Cognitive Decline

Ibogaine's GDNF and BDNF upregulation supports neural repair. Patients with TBI, long-term neurological effects, and early cognitive decline report improvements in memory, focus, and emotional regulation.

Existential & Spiritual Seeking

For patients without a diagnosed condition but seeking profound transformation, 5-MeO-DMT and psilocybin ceremonies provide direct non-dual experience and reconnection to meaning and purpose.

Why Choose MindScape Cozumel

Medical Excellence & Clinical Precision

MindScape Retreat is not a retreat in the conventional sense. We are a medical treatment center staffed by a board-certified physician (Dr. Arellano), licensed nurses, clinical psychologists, and experienced facilitators. Every patient receives a comprehensive cardiac screening, blood work, and psychiatric evaluation before treatment begins.

Our facility in Cozumel combines Caribbean beauty with medical-grade infrastructure. Private rooms with 24/7 monitoring, on-site cardiac equipment, and immediate access to emergency care ensure maximum safety. We maintain 1:1 or 2:1 staff-to-patient ratios during all active treatment phases.

We use pharmaceutical-grade compounds, not street samples. Ibogaine is pharmaceutical HCL or TA, tested for purity and potency. 5-MeO-DMT is pharmaceutical-grade and properly dosed. Every session is facilitated, not merely supervised. Our team works actively throughout the experience to provide emotional support, somatic guidance, and real-time safety management.

Aftercare is integrated into every program. We do not discharge patients and disappear. You receive 6–12 months of remote integration support, including weekly psychotherapy, medication management, and community connection.

Your Treatment Journey

Six Phases of Psychedelic Therapy

01

Initial Screening & Assessment

A 45-minute consultation with Dr. Arellano or our clinical director. We review your medical history, substance use, psychiatric diagnosis, medications, and treatment goals. We determine which modality (ibogaine, 5-MeO-DMT, psilocybin, or combination) is clinically appropriate for you.

02

Comprehensive Medical Workup

Blood work (CBC, comprehensive metabolic panel, liver/kidney function, lipid profile). EKG and cardiac screening (essential for ibogaine). Psychiatric evaluation and substance use assessment. We may consult with your home physician to ensure medical clearance.

03

Pre-Treatment Preparation

Dietary guidelines, medication adjustments, and possible tapering of sedating medications (under physician supervision). Psychoeducation: detailed explanation of the medicine, what to expect, safety protocols, and integration principles. Intention-setting ceremony to clarify your healing goals.

04

Treatment Day(s)

Patients arrive in Cozumel 1–2 days early for acclimation. Treatment occurs in our private medical suite. Heart rate, blood pressure, and oxygen are monitored continuously. Dosing is tailored to your weight, metabolism, and clinical presentation. Sessions last 12–36 hours depending on the modality.

05

Immediate Integration (Days 2-7)

Most patients stay 5-7 days post-treatment. We provide daily psychotherapy, somatic integration work, nutritional support, and grounding in nature. This is the most therapeutically productive window. Insights crystallize; new neural pathways solidify. Sleep, nutrition, and emotional support are prioritized.

06

Long-Term Integration & Aftercare

Upon return home, you receive 6-12 months of remote psychotherapy (weekly initially, then bi-weekly). We coordinate with your home psychiatrist, manage medication adjustments, and support behavioral change. Community connection and peer support groups provide ongoing cohesion.

Safety Profile

Medical Safety & Risk Mitigation

Psychedelic therapy carries minimal physical risk when administered by trained medical professionals in a controlled setting. Ibogaine's cardiac effects are well-understood and manageable with proper screening and monitoring. Our cardiac protocols exceed the standard of care at most U.S. hospitals.

Psychological safety requires proper selection (excluding untreated psychosis, acute bipolar disorder, and certain other conditions), comprehensive preparation, a safe setting, and professional integration support. We provide all four. We do not treat patients who are actively psychotic, actively suicidal, or medically unstable.

Risk increases dramatically in uncontrolled or underground settings without medical oversight. We minimize risk through: board-certified physician oversight, continuous cardiac/vital monitoring, pharmaceutical-grade compounds, 1:1 staff support, and 6–12 months of post-treatment psychotherapy. Your safety is our highest priority.

Cozumel Location

Why the Caribbean Island

Cozumel is not Cancun. While only 45 minutes from the mainland and international airport, Cozumel is a quiet island with Caribbean culture, pristine beaches, and a peaceful rhythm. This matters during integration.

Patients typically report that the natural beauty—the Caribbean sun, the cenotes (natural sinkholes with fresh water), the reef ecosystem—amplifies the medicine's capacity for perspective shift and reconnection. You are not in an urban clinic; you are in a place of awe and renewal.

Our facility overlooks the Caribbean. Private rooms open to ocean breezes. Many patients spend post-treatment days in our garden, swimming, journaling, and walking the beach—activities that themselves facilitate integration and neurological settling.

Cozumel offers all modern amenities (excellent restaurants, pharmacies, healthcare), while maintaining the restorative quality of an island retreat.

Common Questions

Psychedelic Therapy in Mexico: Your Questions Answered

Yes, in Mexico. Ibogaine is not on the controlled substances list and can be legally administered. 5-MeO-DMT and psilocybin exist in a regulated space; MindScape operates within Mexico's medical framework with full compliance. U.S. citizens traveling to Mexico for treatment incur no legal consequences under U.S. law, as you have not broken domestic law by receiving treatment abroad. However, we strongly recommend consulting a lawyer familiar with your home jurisdiction before traveling.

Ibogaine HCL is a purified alkaloid extracted from the iboga root. It produces a rapid flood-dose experience (6–36 hours) with strong visual and introspective effects. Ibogaine TA (Total Alkaloid) retains all 12 natural alkaloids from the root, preserving the plant's full biochemistry. TA provides gentler onset, longer duration, greater emotional depth, and additional neuroprotective benefits. MindScape is the only center that uses both: TA boosters prepare the brain; the HCL flood provides the primary healing experience.

Programs range from 7 days to 14 days. A typical 7-day program includes 2–3 days of preparation, 1–2 days of active treatment (the flood session lasts 12–36 hours), and 3–5 days of integration in Cozumel. After return home, you receive 6–12 months of remote psychotherapy and integration support. Longer programs (10–14 days) are available for patients with severe addiction, complex trauma, or those combining ibogaine with 5-MeO-DMT or psilocybin.

Yes, when administered by medical professionals in a controlled setting with proper screening and monitoring. We exclude patients with untreated psychosis, acute bipolar disorder, severe cardiac disease, or active suicidality. Every patient receives comprehensive medical and psychiatric evaluation. During treatment, heart rate, blood pressure, and oxygen are monitored continuously. Our cardiac protocols exceed standard hospital care. Post-treatment psychotherapy and medical oversight further minimize psychological risk. The greatest danger comes from uncontrolled or underground settings without medical oversight.

Primarily: opioid and substance addiction, treatment-resistant depression, PTSD and complex trauma, anxiety disorders, traumatic brain injury, and existential suffering or spiritual seeking. Psychedelics work by restoring neuroplasticity, dissolving rigid thought patterns, and reconnecting patients to emotion, meaning, and possibility. They are not a substitute for ongoing therapy or medication management, but rather a catalyst that enables faster and deeper healing.

Success rates vary by condition. For opioid addiction, 70–80% of patients achieve long-term abstinence (6+ months) when combined with aftercare. For treatment-resistant depression, 60–75% report significant symptom reduction lasting months or years. For PTSD, similar symptom reduction is observed. These figures come from published research and our own clinical outcomes. Success requires commitment: preparation, integration, and ongoing psychotherapy are essential.

Yes. Our most advanced protocols combine ibogaine (foundation, neuroplasticity), 5-MeO-DMT (ego dissolution, peace), and psilocybin (insight, emotional processing). Ibogaine boosters (TA) are given for several days, priming the brain; the HCL flood follows; integration occurs for 5–7 days; then 5-MeO-DMT or psilocybin is administered in a fully prepared neurological substrate. This synergistic approach is more powerful than any single medicine alone.

Programs range from $5,000 (short ibogaine protocol) to $20,000+ (extended multi-modality retreats). See our Pricing page for transparent cost breakdown. Many patients use medical loans, payment plans, or insurance (some policies cover addiction treatment even if the provider is international). Financing is available.

Aftercare is integrated into every program. You receive 6–12 months of remote weekly psychotherapy, psychiatric oversight, medication management, and peer support access. Integration is the hardest part. Insights gained during treatment must be woven into daily life through ongoing therapeutic work. We do not abandon you after the treatment session.

Contact us via our screening form at /contact-mindscape-retreat. A member of our clinical team will review your case, answer questions, and determine if you are a candidate. If appropriate, we will schedule a consultation with Dr. Arellano. From there, we coordinate medical workup, travel arrangements, and your treatment plan.

Take the First Step

Ready to Explore Legal Psychedelic Therapy?

Our medical team is available to discuss your specific situation, treatment options, and suitability for psychedelic therapy in Cozumel.

Begin Your Screening

Explore Our Treatment Options

Ibogaine Treatment →5-MeO-DMT Therapy →Psilocybin Retreat →Plans & Pricing →Safety Standards →